** Veradigm Inc's shares MDRX.O up 3.5% at $18.50 before
the bell
** Healthcare IT firm announced new share repurchase program
for up to $250 million of its common stock urn:newsml:reuters.com:*:nBwbGpYVMa
** New share repurchase program replaces the previous
authorization to repurchase $250 million of common stock which
was almost fully utilized during 2022 - MDRX
** Co sees 2023 adjusted profit in range of $0.90 per share
and $1.00 per share, in line with analysts' estimate of $0.95
per share - Refinitiv IBES data
** Stock fell ~4% last year
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))